Buckle up, because the markets are crashing, the economists are screaming, and the elephant seals are very confused.

Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations of Paxlovid, currently the most prescribed oral treatment.

For many this will be their fifth year of getting Covid vaccines – and some will ask if it is still worth getting the jab.

Five years since the World Health Organization declared Covid-19 a global pandemic, Europe is still taking stock of what's changed and what hasn't. T ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Pakistan's President Asif Ali Zardari, age 69, has tested positive for COVID and is currently in isolation. After ...

An outbreak within a person’s own community appears to be one of the most potent influences on Americans’ vaccination decisions.

No increased risk for new-onset T2D was found after mild SARS-CoV-2 infection in a multiethnic Asian cohort during the ...

Imposing a vaccine mandate for staff at all nursing homes shortly after COVID shots became available may have saved nearly 10,000 lives.

Experts say LP.8.1’s symptoms align with those of other circulating strains, showing no heightened severity, suggesting it ...

The second infection was also tied to a 50% or greater increase in several specific long-COVID conditions, including ...